IRadimed Corporation (IRMD) vs First Tracks Biotherapeutics Inc (TRAX)

A side-by-side comparison of IRadimed Corporation and First Tracks Biotherapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
IRadimed Corporation logo
IRMD
IRadimed Corporation
$1.08B
$84.82HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
First Tracks Biotherapeutics Inc logo
TRAX
First Tracks Biotherapeutics Inc
$1.10B
$31.39HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — IRMD vs TRAX

growth of $100 · dividends reinvested · last 1y
IRMD -9.8% (-9.8%/yr)TRAX +73.6% (+73.6%/yr)TRAX compounded faster over this window
100150200250Start $100$90$174
IRMD TRAX

IRMD vs TRAX: by the numbers

  • •TRAX is the larger company ($1.10B vs $1.08B market cap).
  • •IRMD is profitable (26.70% net margin) while TRAX runs a net loss (0.00%).
  • •IRMD pays a dividend (1.47% yield), while TRAX has no payments in the available dividend history.

Metrics side by side

Valuation

MetricIRMDTRAX
P/E ratio47.39N/A
Forward P/E40.14N/A
PEG ratio0.64N/A
P/S ratio12.56N/A
P/B ratio10.666.49
EV / EBITDA34.85N/A
FCF yield2.30%N/A

Profitability

MetricIRMDTRAX
Gross margin75.86%0.00%
Operating margin31.92%0.00%
Net margin26.70%0.00%
ROE22.66%-57.77%
ROIC20.18%-59.76%

Dividends

MetricIRMDTRAX
Dividend yield1.47%N/A
Payout ratio70.95%N/A

Growth (annualized)

MetricIRMDTRAX
Revenue CAGR (5Y)19.60%N/A
EPS CAGR (5Y)74.32%N/A
FCF CAGR (5Y)26.20%N/A
Total return CAGR (5Y)24.06%N/A

Frequently asked

Does IRMD or TRAX pay a bigger dividend?
IRMD pays a dividend (1.47% yield), while TRAX has no payments in the available dividend history.
Is IRMD or TRAX more profitable?
IRMD runs the higher net margin — IRMD at 26.70% versus TRAX at 0.00%.

Go deeper

Full IRMD analysisFull TRAX analysisInteractive comparison tool

Dig into the metrics

IRadimed P/E ratioIRadimed dividend yieldIRadimed ROEFirst Tracks Biotherapeutics ROEIRadimed operating marginFirst Tracks Biotherapeutics operating marginIRadimed revenue growthFirst Tracks Biotherapeutics revenue growthIRadimed free cash flowFirst Tracks Biotherapeutics free cash flow

IRadimed & First Tracks Biotherapeutics appear in these rankings

Fastest Revenue Growth StocksHighest ROIC StocksHighest Operating Margin StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.